Algenex raises €7.4 million in financing round
September 08, 2020 07:00 ET
|
Algenex SL
PRESS RELEASE Algenex raises €7.4 million in financing round Madrid (Spain), September 8, 2020.- Algenex SL, a private biotechnology company delivering disruptive technologies for recombinant...
Algenex and Global DX Announce Positive Evaluation of Herdscreen® ASFV Antibody Test for African Swine Fever
July 21, 2020 02:00 ET
|
Algenex SL
PRESS RELEASE Algenex and Global DX Announce Positive Evaluation of Herdscreen® ASFV Antibody Test for African Swine Fever Analysis of this new rapid test at the European Union Reference Laboratory...
Algenex advances insect-based vaccine production technology in human health
May 05, 2020 02:00 ET
|
Algenex SL
PRESS RELEASE Algenex advances insect-based vaccine production technology in human health CrisBio® offers efficient, economic and rapid response tool in pandemics. Madrid, May 5, 2020.- Algenex SL...
Algenex and FATRO sign commercial license agreement for development of a second CrisBio®-based vaccine
December 02, 2019 02:00 ET
|
Algenex SL
PRESS RELEASE Algenex and FATRO sign commercial license agreement for development of a second CrisBio®-based vaccine Agreement strengthens collaboration between the companies...
First Algenex CrisBio®-based vaccine submitted to European Medicines Agency
October 15, 2019 02:00 ET
|
Algenex SL
PRESS RELEASE First Algenex CrisBio®-based vaccine submitted to European Medicines Agency Potential approval would validate the use of Algenex’ CrisBio® technology for the manufacture of...
Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever
May 28, 2019 02:00 ET
|
Algenex SL
PRESS RELEASE Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever Madrid (Spain) and Stirling (UK), May 28, 2019 –...
ALGENEX appoints new Strategic Advisory Board (SAB)
March 13, 2019 08:00 ET
|
Algenex SL
PRESS RELEASE ALGENEX appoints new Strategic Advisory Board (SAB) Advisors include recognized industry leaders in international healthcare Madrid (Spain), March 13, 2019 – ALGENEX SL (the...
ALGENEX closes funding round and strengthens team with key senior manager appointments
March 05, 2019 07:00 ET
|
Algenex SL
PRESS RELEASE ALGENEX closes funding round and strengthens team with key senior manager appointments Madrid (Spain), March 5, 2019 – ALGENEX SL (the “company”), a private biotechnology company...